PMID- 34361038 OWN - NLM STAT- MEDLINE DCOM- 20210908 LR - 20210908 IS - 1422-0067 (Electronic) IS - 1422-0067 (Linking) VI - 22 IP - 15 DP - 2021 Jul 31 TI - Probiotic-Induced Tolerogenic Dendritic Cells: A Novel Therapy for Inflammatory Bowel Disease? LID - 10.3390/ijms22158274 [doi] LID - 8274 AB - Inflammatory bowel diseases (IBDs) are immune-mediated, chronic relapsing diseases with a rising prevalence worldwide in both adult and pediatric populations. Treatment options for immune-mediated diseases, including IBDs, are traditional steroids, immunomodulators, and biologics, none of which are capable of inducing long-lasting remission in all patients. Dendritic cells (DCs) play a fundamental role in inducing tolerance and regulating T cells and their tolerogenic functions. Hence, modulation of intestinal mucosal immunity by DCs could provide a novel, additional tool for the treatment of IBD. Recent evidence indicates that probiotic bacteria might impact immunomodulation both in vitro and in vivo by regulating DCs' maturation and producing tolerogenic DCs (tolDCs) which, in turn, might dampen inflammation. In this review, we will discuss this evidence and the mechanisms of action of probiotics and their metabolites in inducing tolDCs in IBDs and some conditions associated with them. FAU - Baradaran Ghavami, Shaghayegh AU - Baradaran Ghavami S AD - Basic and Molecular Epidemiology of Gastrointestinal Disorders Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran 19839-63113, Iran. FAU - Asadzadeh Aghdaei, Hamid AU - Asadzadeh Aghdaei H AUID- ORCID: 0000-0001-5589-8856 AD - Basic and Molecular Epidemiology of Gastrointestinal Disorders Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran 19839-63113, Iran. FAU - Sorrentino, Dario AU - Sorrentino D AD - IBD Center, Division of Gastroenterology, Virginia Tech Carilion School of Medicine, 3 Riverside Circle, Roanoke, VA 24016, USA. AD - Department of Clinical and Experimental Medical Sciences, University of Udine School of Medicine, 33100 Udine, Italy. FAU - Shahrokh, Shabnam AU - Shahrokh S AD - Basic and Molecular Epidemiology of Gastrointestinal Disorders Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran 19839-63113, Iran. FAU - Farmani, Maryam AU - Farmani M AUID- ORCID: 0000-0001-9941-733X AD - Basic and Molecular Epidemiology of Gastrointestinal Disorders Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran 19839-63113, Iran. FAU - Ashrafian, Fatemeh AU - Ashrafian F AUID- ORCID: 0000-0001-8260-100X AD - Microbiology Research Center, Pasteur Institute of Iran, Tehran 13169-43551, Iran. FAU - Dore, Maria Pina AU - Dore MP AUID- ORCID: 0000-0001-7305-3531 AD - Department di Medical, Surgical and Experimental Sciences, University of Sassari School of Medicine, 07100 Sassari, Italy. FAU - Keshavarz Azizi Raftar, Shahrbanoo AU - Keshavarz Azizi Raftar S AD - Microbiology Research Center, Pasteur Institute of Iran, Tehran 13169-43551, Iran. FAU - Mobin Khoramjoo, Seyed AU - Mobin Khoramjoo S AD - Basic and Molecular Epidemiology of Gastrointestinal Disorders Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran 19839-63113, Iran. FAU - Zali, Mohammad Reza AU - Zali MR AD - Gastroenterology and Liver Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran 19839-63113, Iran. LA - eng PT - Journal Article PT - Review DEP - 20210731 PL - Switzerland TA - Int J Mol Sci JT - International journal of molecular sciences JID - 101092791 SB - IM MH - Animals MH - Dendritic Cells/*immunology MH - Humans MH - Inflammatory Bowel Diseases/diet therapy/*immunology/microbiology MH - Intestinal Mucosa/cytology/immunology MH - Probiotics/*therapeutic use PMC - PMC8348973 OTO - NOTNLM OT - Crohn's disease OT - dendritic cells OT - inflammatory bowel diseases OT - mucosal tolerance OT - probiotics OT - ulcerative colitis COIS- There are no conflict of interest to declare. EDAT- 2021/08/08 06:00 MHDA- 2021/09/09 06:00 PMCR- 2021/07/31 CRDT- 2021/08/07 01:08 PHST- 2021/06/24 00:00 [received] PHST- 2021/07/22 00:00 [revised] PHST- 2021/07/24 00:00 [accepted] PHST- 2021/08/07 01:08 [entrez] PHST- 2021/08/08 06:00 [pubmed] PHST- 2021/09/09 06:00 [medline] PHST- 2021/07/31 00:00 [pmc-release] AID - ijms22158274 [pii] AID - ijms-22-08274 [pii] AID - 10.3390/ijms22158274 [doi] PST - epublish SO - Int J Mol Sci. 2021 Jul 31;22(15):8274. doi: 10.3390/ijms22158274.